{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T23:17:25Z","timestamp":1780442245501,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-HL123255"],"award-info":[{"award-number":["R01-HL123255"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["17PRE33650085"],"award-info":[{"award-number":["17PRE33650085"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["15PRE23020006"],"award-info":[{"award-number":["15PRE23020006"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["12PRE12030412"],"award-info":[{"award-number":["12PRE12030412"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00109-019-01791-z","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T15:42:42Z","timestamp":1558107762000},"page":"1033-1047","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Therapeutic potential of AAV9-S15D-RLC gene delivery in humanized MYL2 mouse model of HCM"],"prefix":"10.1007","volume":"97","author":[{"given":"Sunil","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Ching","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Kazmierczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingsheng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenrui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauro M.","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemeire M.","family":"Kanashiro-Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8441-0722","authenticated-orcid":false,"given":"Danuta","family":"Szczesna-Cordary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,17]]},"reference":[{"key":"1791_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.hfc.2009.12.001","volume":"6","author":"CY Ho","year":"2010","unstructured":"Ho CY (2010) Hypertrophic cardiomyopathy. Heart Fail Clin 6:141\u2013159","journal-title":"Heart Fail Clin"},{"key":"1791_CR2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1540-8167.2007.00965.x","volume":"19","author":"R Alcalai","year":"2008","unstructured":"Alcalai R, Seidman JG, Seidman CE (2008) Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics. J Cardiovasc Electrophysiol 19:104\u2013110","journal-title":"J Cardiovasc Electrophysiol"},{"key":"1791_CR3","first-page":"1308","volume":"287","author":"BJ Maron","year":"2002","unstructured":"Maron BJ (2002) Hypertrophic cardiomyopathy: a systematic review. JAMA 287:1308\u20131320","journal-title":"JAMA"},{"key":"1791_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2174\/1568006033481474","volume":"3","author":"D Szczesna-Cordary","year":"2003","unstructured":"Szczesna-Cordary D (2003) Regulatory light chains of striated muscle myosin. Structure, function and malfunction. Curr Drug Targets Cardiovasc Haematol Disord 3:187\u2013197","journal-title":"Curr Drug Targets Cardiovasc Haematol Disord"},{"key":"1791_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/gim.2014.205","volume":"17","author":"AA Alfares","year":"2015","unstructured":"Alfares AA, Kelly MA, McDermott G, Funke BH, Lebo MS, Baxter SB, Shen J, McLaughlin HM, Clark EH, Babb LJ et al (2015) CORRIGENDUM: results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity. Genet Med 17:319","journal-title":"Genet Med"},{"key":"1791_CR6","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.amjcard.2006.12.087","volume":"99","author":"F Gaita","year":"2007","unstructured":"Gaita F, Di Donna P, Olivotto I, Scaglione M, Ferrero I, Montefusco A, Caponi D, Conte MR, Nistri S, Cecchi F (2007) Usefulness and safety of transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy. Am J Cardiol 99:1575\u20131581","journal-title":"Am J Cardiol"},{"key":"1791_CR7","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1074\/jbc.M307092200","volume":"279","author":"D Szczesna-Cordary","year":"2004","unstructured":"Szczesna-Cordary D, Guzman G, Ng SS, Zhao J (2004) Familial hypertrophic cardiomyopathy-linked alterations in Ca2+ binding of human cardiac myosin regulatory light chain affect cardiac muscle contraction. J Biol Chem 279:3535\u20133542","journal-title":"J Biol Chem"},{"key":"1791_CR8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1126\/science.8316857","volume":"261","author":"I Rayment","year":"1993","unstructured":"Rayment I, Rypniewski WR, Schmidt-Base K, Smith R, Tomchick DR, Benning MM, Winkelmann DA, Wesenberg G, Holden HM (1993) Three-dimensional structure of myosin subfragment-1: a molecular motor. Science 261:50\u201358","journal-title":"Science"},{"key":"1791_CR9","doi-asserted-by":"publisher","first-page":"7086","DOI":"10.1074\/jbc.M009823200","volume":"276","author":"D Szczesna","year":"2001","unstructured":"Szczesna D, Ghosh D, Li Q, Gomes AV, Guzman G, Arana C, Zhi G, Stull JT, Potter JD (2001) Familial hypertrophic cardiomyopathy mutations in the regulatory light chains of myosin affect their structure, Ca2+ binding, and phosphorylation. J Biol Chem 276:7086\u20137092","journal-title":"J Biol Chem"},{"key":"1791_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s12551-017-0248-8","volume":"9","author":"S Yadav","year":"2017","unstructured":"Yadav S, Szczesna-Cordary D (2017) Pseudophosphorylation of cardiac myosin regulatory light chain: a promising new tool for treatment of cardiomyopathy. Biophys Rev 9:57\u201364","journal-title":"Biophys Rev"},{"key":"1791_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4419-9029-7_1","volume":"538","author":"J van der Velden","year":"2003","unstructured":"van der Velden J, Papp Z, Boontje NM, Zaremba R, de Jong JW, Janssen PM, Hasenfuss G, Stienen GJ (2003) Myosin light chain composition in non-failing donor and end-stage failing human ventricular myocardium. Adv Exp Med Biol 538:3\u201315","journal-title":"Adv Exp Med Biol"},{"key":"1791_CR12","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0008-6363(02)00662-4","volume":"57","author":"J van der Velden","year":"2003","unstructured":"van der Velden J, Papp Z, Boontje NM, Zaremba R, de Jong JW, Janssen PML, Hasenfuss G, Stienen GJM (2003) The effect of myosin light chain 2 dephosphorylation on Ca2+-sensitivity of force is enhanced in failing human hearts. Cardiovasc Res 57:505\u2013514","journal-title":"Cardiovasc Res"},{"key":"1791_CR13","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1096\/fj.08-118182","volume":"23","author":"WGL Kerrick","year":"2009","unstructured":"Kerrick WGL, Kazmierczak K, Xu Y, Wang Y, Szczesna-Cordary D (2009) Malignant familial hypertrophic cardiomyopathy D166V mutation in the ventricular myosin regulatory light chain causes profound effects in skinned and intact papillary muscle fibers from transgenic mice. FASEB J 23:855\u2013865","journal-title":"FASEB J"},{"key":"1791_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/cvr\/cvp016","volume":"82","author":"TP Abraham","year":"2009","unstructured":"Abraham TP, Jones M, Kazmierczak K, Liang H-Y, Pinheiro AC, Wagg CS, Lopaschuk GD, Szczesna-Cordary D (2009) Diastolic dysfunction in familial hypertrophic cardiomyopathy transgenic model mice. Cardiovasc Res 82:84\u201392","journal-title":"Cardiovasc Res"},{"key":"1791_CR15","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.1074\/jbc.M807414200","volume":"284","author":"SB Scruggs","year":"2009","unstructured":"Scruggs SB, Hinken AC, Thawornkaiwong A, Robbins J, Walker LA, de Tombe PP, Geenen DL, Buttrick PM, Solaro RJ (2009) Ablation of ventricular myosin regulatory light chain phosphorylation in mice causes cardiac dysfunction in situ and affects neighboring myofilament protein phosphorylation. J Biol Chem 284:5097\u20135106","journal-title":"J Biol Chem"},{"key":"1791_CR16","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1172\/JCI61134","volume":"122","author":"F Sheikh","year":"2012","unstructured":"Sheikh F, Ouyang K, Campbell SG, Lyon RC, Chuang J, Fitzsimons D, Tangney J, Hidalgo CG, Chung CS, Cheng H, Dalton ND, Gu Y, Kasahara H, Ghassemian M, Omens JH, Peterson KL, Granzier HL, Moss RL, McCulloch AD, Chen J (2012) Mouse and computational models link Mlc2v dephosphorylation to altered myosin kinetics in early cardiac disease. J Clin Invest 122:1209\u20131221","journal-title":"J Clin Invest"},{"key":"1791_CR17","doi-asserted-by":"publisher","first-page":"19748","DOI":"10.1074\/jbc.M802605200","volume":"283","author":"J Huang","year":"2008","unstructured":"Huang J, Shelton JM, Richardson JA, Kamm KE, Stull JT (2008) Myosin regulatory light chain phosphorylation attenuates cardiac hypertrophy. J Biol Chem 283:19748\u201319756","journal-title":"J Biol Chem"},{"key":"1791_CR18","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1161\/CIRCULATIONAHA.112.116202","volume":"126","author":"SA Warren","year":"2012","unstructured":"Warren SA, Briggs LE, Zeng H, Chuang J, Chang EI, Terada R, Li M, Swanson MS, Lecker SH, Willis MS, Spinale FG, Maupin-Furlowe J, McMullen JR, Moss RL, Kasahara H (2012) Myosin light chain phosphorylation is critical for adaptation to cardiac stress. Circulation 126:2575\u20132588","journal-title":"Circulation"},{"key":"1791_CR19","doi-asserted-by":"publisher","first-page":"E4138","DOI":"10.1073\/pnas.1505819112","volume":"112","author":"CC Yuan","year":"2015","unstructured":"Yuan CC, Muthu P, Kazmierczak K, Liang J, Huang W, Irving TC, Kanashiro-Takeuchi RM, Hare JM, Szczesna-Cordary D (2015) Constitutive phosphorylation of cardiac myosin regulatory light chain prevents development of hypertrophic cardiomyopathy in mice. Proc Natl Acad Sci U S A 112:E4138\u2013E4146","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1791_CR20","first-page":"383","volume-title":"Cardiomyopathies \u2013 from basic research to clinical management. Ch. 17","author":"P Muthu","year":"2012","unstructured":"Muthu P, Huang W, Kazmierczak K, Szczesna-Cordary D (2012) Functional consequences of mutations in the myosin regulatory light chain associated with hypertrophic cardiomyopathy. In: Veselka J (ed) Cardiomyopathies \u2013 from basic research to clinical management. Ch. 17. InTech, Croatia, pp 383\u2013408"},{"key":"1791_CR21","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1161\/01.CIR.0000066323.15244.54","volume":"107","author":"P Richard","year":"2003","unstructured":"Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M et al (2003) Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 107:2227\u20132232 and erratum (2004), 2109(2225), p.3258","journal-title":"Circulation"},{"key":"1791_CR22","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/j.1582-4934.2011.01371.x","volume":"16","author":"P Muthu","year":"2012","unstructured":"Muthu P, Kazmierczak K, Jones M, Szczesna-Cordary D (2012) The effect of myosin RLC phosphorylation in normal and cardiomyopathic mouse hearts. J Cell Mol Med 16:911\u2013919","journal-title":"J Cell Mol Med"},{"key":"1791_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.abb.2013.12.011","volume":"552-553","author":"P Muthu","year":"2014","unstructured":"Muthu P, Liang J, Schmidt W, Moore JR, Szczesna-Cordary D (2014) In vitro rescue study of a malignant familial hypertrophic cardiomyopathy phenotype by pseudo-phosphorylation of myosin regulatory light chain. Arch Biochem Biophys 552-553:29\u201339","journal-title":"Arch Biochem Biophys"},{"key":"1791_CR24","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1089\/hum.2008.123","volume":"19","author":"LT Bish","year":"2008","unstructured":"Bish LT, Morine K, Sleeper MM, Sanmiguel J, Wu D, Gao G, Wilson JM, Sweeney HL (2008) Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat. Hum Gene Ther 19:1359\u20131368","journal-title":"Hum Gene Ther"},{"key":"1791_CR25","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/jgm.2673","volume":"14","author":"PR Konkalmatt","year":"2012","unstructured":"Konkalmatt PR, Wang F, Piras BA, Xu Y, O\u2019Connor DM, Beyers RJ, Epstein FH, Annex BH, Hossack JA, French BA (2012) Adeno-associated virus serotype 9 administered systemically after reperfusion preferentially targets cardiomyocytes in the infarct border zone with pharmacodynamics suitable for the attenuation of left ventricular remodeling. J Gene Med 14:609\u2013620","journal-title":"J Gene Med"},{"key":"1791_CR26","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/sj.gt.3302895","volume":"14","author":"J Palomeque","year":"2007","unstructured":"Palomeque J, Chemaly ER, Colosi P, Wellman JA, Zhou S, Del Monte F, Hajjar RJ (2007) Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo. Gene Ther 14:989\u2013997","journal-title":"Gene Ther"},{"key":"1791_CR27","doi-asserted-by":"publisher","first-page":"E2338","DOI":"10.1073\/pnas.1716925115","volume":"115","author":"CC Yuan","year":"2018","unstructured":"Yuan CC, Kazmierczak K, Liang J, Zhou Z, Yadav S, Gomes AV, Irving TC, Szczesna-Cordary D (2018) Sarcomeric perturbations of myosin motors lead to dilated cardiomyopathy in genetically modified MYL2 mice. Proc Natl Acad Sci U S A 115:E2338\u2013E2347","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1791_CR28","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jmb.2006.06.018","volume":"361","author":"Y Wang","year":"2006","unstructured":"Wang Y, Xu Y, Kerrick WGL, Wang Y, Guzman G, Diaz-Perez Z, Szczesna-Cordary D (2006) Prolonged Ca2+ and force transients in myosin RLC transgenic mouse fibers expressing malignant and benign FHC mutations. J Mol Biol 361:286\u2013299","journal-title":"J Mol Biol"},{"key":"1791_CR29","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1093\/cvr\/cvx060","volume":"113","author":"CC Yuan","year":"2017","unstructured":"Yuan CC, Kazmierczak K, Liang J, Kanashiro-Takeuchi R, Irving TC, Gomes AV, Wang Y, Burghardt TP, Szczesna-Cordary D (2017) Hypercontractile mutant of ventricular myosin essential light chain leads to disruption of sarcomeric structure and function and results in restrictive cardiomyopathy in mice. Cardiovasc Res 113:1124\u20131136","journal-title":"Cardiovasc Res"},{"key":"1791_CR30","first-page":"357","volume":"26","author":"C Tei","year":"1995","unstructured":"Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ, Tajik AJ, Seward JB (1995) New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function--a study in normals and dilated cardiomyopathy. J Cardiol 26:357\u2013366","journal-title":"J Cardiol"},{"key":"1791_CR31","doi-asserted-by":"publisher","first-page":"10703","DOI":"10.1074\/jbc.M115.642165","volume":"290","author":"AN Chang","year":"2015","unstructured":"Chang AN, Battiprolu PK, Cowley PM, Chen G, Gerard RD, Pinto JR, Hill JA, Baker AJ, Kamm KE, Stull JT (2015) Constitutive phosphorylation of cardiac myosin regulatory light chain in vivo. J Biol Chem 290:10703\u201310716","journal-title":"J Biol Chem"},{"key":"1791_CR32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1042\/bj1350151","volume":"135","author":"WT Perrie","year":"1973","unstructured":"Perrie WT, Smillie LB, Perry SB (1973) A phosphorylated light-chain component of myosin from skeletal muscle. Biochem J 135:151\u2013164","journal-title":"Biochem J"},{"key":"1791_CR33","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.yjmcc.2014.06.011","volume":"74","author":"W Huang","year":"2014","unstructured":"Huang W, Liang J, Kazmierczak K, Muthu P, Duggal D, Farman GP, Sorensen L, Pozios I, Abraham T, Moore JR et al (2014) Hypertrophic cardiomyopathy associated Lys104Glu mutation in the myosin regulatory light chain causes diastolic disturbance in mice. J Mol Cell Cardiol 74:318\u2013329","journal-title":"J Mol Cell Cardiol"},{"key":"1791_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0008-6363(02)00606-5","volume":"57","author":"J van der Velden","year":"2003","unstructured":"van der Velden J, Papp Z, Zaremba R, Boontje NM, de Jong JW, Owen VJ, Burton PBJ, Goldmann P, Jaquet K, Stienen GJM (2003) Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins. Cardiovasc Res 57:37\u201347","journal-title":"Cardiovasc Res"},{"key":"1791_CR35","doi-asserted-by":"publisher","first-page":"E3824","DOI":"10.1073\/pnas.1600633113","volume":"113","author":"AN Chang","year":"2016","unstructured":"Chang AN, Mahajan P, Knapp S, Barton H, Sweeney HL, Kamm KE, Stull JT (2016) Cardiac myosin light chain is phosphorylated by Ca2+\/calmodulin-dependent and -independent kinase activities. Proc Natl Acad Sci U S A 113:E3824\u2013E3833","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1791_CR36","doi-asserted-by":"publisher","first-page":"9148","DOI":"10.1073\/pnas.1511455112","volume":"112","author":"HL Granzier","year":"2015","unstructured":"Granzier HL, de Tombe PP (2015) Myosin light chain phosphorylation to the rescue. Proc Natl Acad Sci U S A 112:9148\u20139149","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1791_CR37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/gt.2010.105","volume":"18","author":"K-MR Prasad","year":"2011","unstructured":"Prasad K-MR, Xu Y, Yang Z, Acton ST, French BA (2011) Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution. Gene Ther 18:43\u201352","journal-title":"Gene Ther"},{"key":"1791_CR38","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1053\/euhj.2000.2246","volume":"21","author":"C Bruch","year":"2000","unstructured":"Bruch C, Schmermund A, Marin D, Katz M, Bartel T, Schaar J, Erbel R (2000) Tei-index in patients with mild-to-moderate congestive heart failure. Eur Heart J 21:1888\u20131895","journal-title":"Eur Heart J"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-019-01791-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-019-01791-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-019-01791-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T05:31:58Z","timestamp":1721280718000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-019-01791-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,17]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["1791"],"URL":"https:\/\/doi.org\/10.1007\/s00109-019-01791-z","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,17]]},"assertion":[{"value":"14 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}